Keyphrases
Antiepileptic Drugs
100%
Valproic Acid
86%
Indocyanine Green
71%
Antiseizure Medication
71%
P-glycoprotein (P-gp)
66%
Drug Interactions
60%
Blood-brain Barrier
59%
Pharmacokinetics
59%
Seizure
55%
P-glycoprotein Activity
44%
International League Against Epilepsy
42%
Human Placenta
41%
Epilepsy
38%
Valproate
37%
During Pregnancy
34%
Placenta
33%
Molecular Imaging
32%
Drug Transporters
32%
P-glycoprotein Inhibitor
30%
Pregnant Women
30%
Liposomal
29%
Verapamil
29%
Fetus
28%
Israeli
28%
Cyclosporine
27%
Nonhuman Primate
27%
Israel
25%
Lactation
24%
Epileptic Rats
24%
Lacosamide
24%
Lamotrigine
23%
Carbamazepine
23%
Controlled Release
23%
Positron Emission Tomography
22%
Tumor
22%
Antiseizure
21%
Drug Distribution
21%
Multidrug Resistance Protein 1 (MDR1)
19%
Pharmacodynamics
19%
Liposomes
19%
Placental Barrier
19%
Levetiracetam
18%
Inflammation
18%
Brain Tissue
18%
Therapeutic Concentrations
18%
Histone Deacetylases
18%
Histone Acetylation
18%
Pregnant Rats
17%
Transporter Expression
17%
Triple-negative Breast Cancer Cells
17%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Valproate
94%
Pharmacokinetic
90%
Anticonvulsive Agent
80%
P-Glycoprotein
63%
Indocyanine Green
54%
Neoplasm
50%
Blood-Brain Barrier
49%
Drug Interaction
47%
Effusion
34%
Diseases
32%
Pharmacodynamics
31%
Drug-Drug Interaction
29%
Doxorubicin
24%
Polyethylene Terephthalate
24%
Inflammation
24%
Lacosamide
23%
Controlled Release
22%
Adverse Drug Reaction
21%
Carbamazepine
21%
Lamictal
20%
Folic Acid
20%
Carbon 11
20%
Malignant Neoplasm
20%
Histone Deacetylase
18%
Ciclosporin
18%
ABCG2
18%
Verapamil
18%
Drug Distribution
18%
CYP2D6
17%
Pharmacotherapy
17%
Carrier Protein
17%
Histone
17%
Dosage Form
16%
Allergic Reaction
16%
Cardiovascular Agent
16%
Nanoparticle
16%
Magnetic Nanoparticle
16%
Liposome
15%
Side Effect
15%
Levetiracetam
14%
Messenger RNA
13%
Multidrug Resistance Protein 1
13%
Adverse Event
12%
Macaca
11%
CYP3A
11%
Leukocyte Antigen
10%
Phenytoin
10%
Histone Deacetylase Inhibitor
10%
Valspodar
10%
Optical Imaging
9%